PR Newswire Asia's news

 |   Title only   |   Print    Next page > 
     
Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer
HONG KONG , July 16, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been successfully enrolled in the registration ...
2025-07-16T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures
DONGGUAN, China , July 16, 2025 /PRNewswire/ -- Amid mounting pressures from the ongoing U.S.–China tariff conflict, Chinese manufacturers are accelerating their digital transformation to remain competitive. ...
2025-07-16T    Computer/Electronics   Mining/Metals 
ArkBio's Ziresovir Included into Pediatric RSV Drug Priority List by WHO
SHANGHAI , July 16, 2025 /PRNewswire/ -- In the newly released "Paediatric drug optimization for respiratory syncytial virus (PADO-RSV) meeting report" by Global Accelerator for Paediatric ...
2025-07-16T    Biotechnology   Health Care/Hospital   Infectious Disease Control   Medical/Pharmaceuticals 
TIER IV unveils end-to-end architecture for Level 4+ autonomy: To be demonstrated across 50 locations nationwide
TOKYO , July 16, 2025 /PRNewswire/ --  TIER IV , the pioneering force behind the world's first open-source software for autonomous driving, has developed an end-to-end architecture for Level 4+ ...
2025-07-16T    Auto   Computer/Electronics   Transportation 
AbbVie's 10th 'Week of Possibilities' Unites Employees Across Asia for Community Impact
-          880 AbbVie employees across 7 markets volunteered over 3,000 hours to support vulnerable groups. -          ...
2025-07-16T    Banking/Financial Service   Environmental Products & Services   Green Technology   Health Care/Hospital 
PHASE Scientific Expands INDICAID® Respiratory Portfolio with Exclusive U.S. Launch of Novel FebriDx® Test
FebriDx ® is a first-in-class rapid test that differentiates between bacterial and non-bacterial respiratory infections, offering significant potential to address critical unmet needs in patient care ...
2025-07-16T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Global Times: Xi's vision of a people-centered city guides China's urban development
BEIJING , July 16, 2025 /PRNewswire/ -- "Cities should be built by the people and for the people"; "a city should not only have high-rise buildings, and it must also show enough concern ...
2025-07-16T    Computer/Electronics   Multimedia/Online/Internet   Publishing/Information Service 
NetGain Systems Launches Astra AI, the World's First Large Language Model Purpose-Built for IT Asset Observability and Management
Astra evolves how enterprises anticipate and resolve IT issues before  they disrupt businesses and their complex digital infrastructures. ...
2025-07-16T    Internet Technology   Telecommunications 
Autonomous Agents Set to Revolutionise Transportation Management
Global research from Manhattan Associates finds integration difficulties and data quality remain significant hurdles for organisations looking to leverage AI across transportation management ...
2025-07-16T    Computer/Electronics   Retail   Transportation 
CNOOC Limited Achieves Major Exploration Breakthrough in the Deep Plays of the South China Sea
HONG KONG , July 16, 2025 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) today announces that it has achieved a major breakthrough ...
2025-07-16T    Banking/Financial Service   Oil/Energy 
  Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.